7-3-1 Hongo, Bunkyo-ku
Tokyo 113-0033
Japan
University of Tokyo
SSRN RANKINGS
in Total Papers Downloads
in Total Papers Citations
agency problem, financial incentive, generic drugs
pharmaceutical policy, agency problem, drug pricing
Prescription drug, advertising, direct-to-consumer, market expanding, business stealing, information
Prescription drug, advertising, direct-to-consumer, market expanding
medical liability, patient safety, PSI, defensive medicine, tort reform, health outcomes, malpractice risks
medical liability, patient safety, defensive medicine, tort reform, malpractice risks
kill-off used durable, Durable goods, markets for new and used goods, secondhand market, planned obsolescence
principal agent problem, pharmaceutical, physician induced demand
kill-off used durables, durable goods, market for used and new goods, secondhand
generic entry, prescription drug, entry regulation, price control
Pay-for-performance; Long-term Care; Vertical Integration; Selective Referral; Difference-in-differences; Japanese Long-Term Care Insurance
Zero-price Effects, Patient Cost-Sharing, Children, Healthcare Utilization, Price Elasticity, Moral Hazard
Medical spending, cost sharing, price elasticity, elderly population
physician labor market, physician wage, hospital exit, health outcome
rare and intractable disease, innovation policy, demand-side policy, pull policy, clinical trial, patient cost sharing
rare and intractable diseases, innovation policy, demand-side and supply-side policies, push and pull policies, clinical trial, patient cost sharing
Asymmetric Demand Response, Loss Aversion, Prospect Theory, Patient Cost-Sharing, Child Healthcare
This is a National Bureau of Economic Research Paper. NBER charges a fee of $5.00 for this paper.
File name: nber.pdf Size: 0K
If you wish to purchase the right to make copies of this paper for distribution to others, please select the quantity.
direct-to-consumer, advertising, prescription drugs, market expanding, business stealing
